Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Events / Business / Cytek Biosciences to present at...
Business conference participation

Cytek Biosciences to present at Singular Research Conference

Analysis based on 6 articles · First reported Jun 10, 2026 · Last updated Jun 10, 2026

Sentiment
10
Attention
1
Articles
6
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The participation of Cytek Biosciences in the Singular Research's Las Vegas Invitational Conference could positively impact its stock price by increasing investor awareness and confidence. This event provides a platform for the company to showcase its cell analysis solutions and engage with potential investors, potentially leading to increased investment.

Biotechnology Medical Devices
Event Summary

Cytek Biosciences, a cell analysis solutions company, announced its participation in the Singular Research's Las Vegas Invitational Conference, scheduled for June 14-16, 2026. Management from Cytek Biosciences is slated to deliver a presentation on June 15th at 11:00 a.m. Pacific Time, which will be accessible via a live and archived webcast on the company's investor relations website. This event offers Cytek Biosciences an opportunity to present its patented Full Spectrum Profiling (FSP) technology and other cell analysis tools to a broader audience of financial market participants.

Key Actions
90 Cytek Biosciences announced participation
Entities Involved
stock
Cytek Biosciences
Cytek Biosciences is participating in the Singular Research's Las Vegas Invitational Conference, which provides an opportunity to present its cell analysis solutions to investors and potentially increase its visibility and investor interest.
Importance 100 Sentiment 10
priv
Singular Research
Singular Research is hosting the Las Vegas Invitational Conference, providing a platform for companies like Cytek Biosciences to present to investors.
Importance 50 Sentiment 0
index
Nasdaq-100
Nasdaq-100 is the stock exchange where Cytek Biosciences is listed, indicating its public trading status.
Importance 10 Sentiment 0
govactor
United States — United States Securities and Exchange Commission
The United States — United States Securities and Exchange Commission is mentioned in the context of Cytek Biosciences' disclosure obligations under Regulation FD.
Importance 5 Sentiment 0
per
Stephanie Olsen
Stephanie Olsen is the Media Contact for Cytek Biosciences through Lages & Associates.
Importance 5 Sentiment 0
priv
Lages & Associates
Lages & Associates is the media contact agency for Cytek Biosciences.
Importance 5 Sentiment 0
per
Paul Goodson
Paul Goodson is the Head of Investor Relations for Cytek Biosciences.
Importance 5 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.